Chongqing - In an exclusive interview with Bridging News at the China International Import Expo (CIIE) in Chongqing Investment Promotion on April 2, Li Ping, VP of Government Affairs and Market Access of BD Greater China spotlighted Chongqing as crucial to the company's growth and a key market for foreign firms.
Around 90% of Chongqing hospital patients use BD products
"Chongqing serves as a strategic linchpin in the broader development of the western region in China, owing to its abundant medical resources and talent pool," stated Li.
Leveraging Chongqing's strong manufacturing and digital base, BD seeks to enhance future collaborations, including digital advancements in healthcare and deeper partnerships with the city, Li added.
BD's longstanding collaboration with Chongqing is evidenced by its extensive presence in the city's medical institutions, with widespread adoption of BD's innovative technologies and products.
"We've cultivated extensive collaborations with Chongqing in the past," Li affirmed. Across all levels of medical institutions in Chongqing, BD's innovative technologies and products have been significantly uptaken. Notably, approximately 90% of patients in Chongqing hospitals utilize BD products.
"This is a source of immense pride for us, motivating continued investment in Chongqing and further collaborations with the city," Li stated.
BD targets local partnerships for the medical device ecosystem
Chongqing has been designated by the National Healthcare Security Administration as a pilot area for digitizing healthcare insurance, highlighting the city's resources in healthcare digitalization and the need for developing new products.
"So, from a market-oriented perspective, the support of healthcare big data is crucial," Li added. BD aims to use healthcare big data to improve healthcare resources, offer innovative solutions for professionals, enhance patient services, and open avenues for digital R&D.
Li said that aligned with Chongqing's biopharmaceutical focus in the 14th Five-Year Plan, BD seeks to partner with local healthcare and regulatory bodies to lead and deepen cooperation in the medical device ecosystem.
He continued, amid the development of the Chengdu-Chongqing economic corridor and increasing population, BD aims to enhance its localization in Southwest China, leveraging both Chongqing and Chengdu's rich healthcare resources and dense population.
"So Chongqing's status as a strategic linchpin in Southwest China holds undeniable allure for multinational corporations seeking to expand their footprint beyond coastal hubs," said Li.
BD is one of the largest global medical technology companies. The company develops innovative technology, services, and solutions that help advance clinical therapy for patients and clinical processes for healthcare providers.
(Deng Yawen, as an intern, also contributed to this report.)